Business Description
HCA Healthcare Inc
NAICS : 622110
SIC : 8062
ISIN : US40412C1018
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -0.03 | |||||
Debt-to-Equity | -23.6 | |||||
Debt-to-EBITDA | 3.29 | |||||
Interest Coverage | 4.97 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.59 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.2 | |||||
3-Year EBITDA Growth Rate | 17.6 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year FCF Growth Rate | -3.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 9.44 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 4.75 | |||||
9-Day RSI | 14.05 | |||||
14-Day RSI | 23.77 | |||||
6-1 Month Momentum % | 35.41 | |||||
12-1 Month Momentum % | 21.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.18 | |||||
Quick Ratio | 1.02 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 75.6 | |||||
Days Sales Outstanding | 51.01 | |||||
Days Payable | 148.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.81 | |||||
Dividend Payout Ratio | 0.13 | |||||
3-Year Dividend Growth Rate | 77.4 | |||||
Forward Dividend Yield % | 0.87 | |||||
5-Year Yield-on-Cost % | 1.7 | |||||
3-Year Average Share Buyback Ratio | 7.9 | |||||
Shareholder Yield % | 4.25 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.76 | |||||
Operating Margin % | 14.82 | |||||
Net Margin % | 8.07 | |||||
FCF Margin % | 7.21 | |||||
ROE % | Neg. Equity | |||||
ROA % | 9.72 | |||||
ROIC % | 17.29 | |||||
ROC (Joel Greenblatt) % | 29.63 | |||||
ROCE % | 22.74 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 16.08 | |||||
Forward PE Ratio | 15 | |||||
PE Ratio without NRI | 16.07 | |||||
Shiller PE Ratio | 23.54 | |||||
Price-to-Owner-Earnings | 17.58 | |||||
PEG Ratio | 1.12 | |||||
PS Ratio | 1.28 | |||||
Price-to-Free-Cash-Flow | 17.93 | |||||
Price-to-Operating-Cash-Flow | 8.92 | |||||
EV-to-EBIT | 12.39 | |||||
EV-to-Forward-EBIT | 11.98 | |||||
EV-to-EBITDA | 9.39 | |||||
EV-to-Forward-EBITDA | 9.04 | |||||
EV-to-Revenue | 1.84 | |||||
EV-to-Forward-Revenue | 1.73 | |||||
EV-to-FCF | 25.49 | |||||
Price-to-Projected-FCF | 1.29 | |||||
Price-to-DCF (Earnings Based) | 0.58 | |||||
Price-to-DCF (FCF Based) | 0.71 | |||||
Price-to-Median-PS-Value | 1.38 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.98 | |||||
Earnings Yield (Greenblatt) % | 8.07 | |||||
FCF Yield % | 5.81 | |||||
Forward Rate of Return (Yacktman) % | 21.5 |